首页> American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons> High tacrolimus trough level variability is associated with rejections after heart transplant.

High tacrolimus trough level variability is associated with rejections after heart transplant.

导出 LinkOut

翻译打印收藏纠错

第一作者： Itai,Gueta

第一单位： The Institute of Clinical Pharmacology, Sheba Medical Center, Tel Hashomer, Israel.;Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

作者： Itai,Gueta ^[1] ; Noa,Markovits ^[1] ; Havatzelet,Yarden-Bilavsky ^[1] ; Eugenia,Raichlin ^[2] ; Dov,Freimark ^[3] ; Jacob,Lavee ^[3] ; Ronen,Loebstein ^[1] ; Yael,Peled ^[3]

作者单位： The Institute of Clinical Pharmacology, Sheba Medical Center, Tel Hashomer, Israel.;Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. ^[1] Division of Cardiology, University of Nebraska Medical Center, Omaha, NE, USA. ^[2] Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.;The Olga and Lev Leviev Heart Center, Sheba Medical Center, Ramat Gan, Israel. ^[3]

关键词 clinical research / practice drug toxicity heart transplantation / cardiology immunosuppressant - calcineurin inhibitor: tacrolimus organ transplantation in general pharmacokinetics / pharmacodynamics pharmacology rejection risk assessment / risk stratification